Acelarin

≥99%

  • Product Code: 99381
  CAS:    840506-29-8
Molecular Weight: 580.47 g./mol Molecular Formula: C₂₅H₂₇F₂N₄O₈P
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: Acelarin is primarily investigated for its potential use in cancer treatment, particularly in chemotherapy. It functions as a prodrug of gemcitabine, which means it is metabolized in the body to release the active drug. This approach aims to enhance the delivery of gemcitabine to cancer cells while minimizing its impact on healthy tissues, thereby improving therapeutic efficacy and reducing side effects. Acelarin has shown promise in targeting hard-to-treat cancers, such as ovarian cancer and pancreatic cancer, where traditional treatments often face limitations. Its development represents an effort to overcome drug resistance and improve patient outcomes in oncology.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days ฿4,356.00
+
-
0.005 10-20 days ฿8,613.00
+
-
0.025 10-20 days ฿27,522.00
+
-
0.100 10-20 days ฿64,233.00
+
-
Acelarin
Acelarin is primarily investigated for its potential use in cancer treatment, particularly in chemotherapy. It functions as a prodrug of gemcitabine, which means it is metabolized in the body to release the active drug. This approach aims to enhance the delivery of gemcitabine to cancer cells while minimizing its impact on healthy tissues, thereby improving therapeutic efficacy and reducing side effects. Acelarin has shown promise in targeting hard-to-treat cancers, such as ovarian cancer and pancreatic cancer, where traditional treatments often face limitations. Its development represents an effort to overcome drug resistance and improve patient outcomes in oncology.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :